146 related articles for article (PubMed ID: 28682845)
1. Incidental Papillary Bladder Carcinoma on 18F-Fluoromethylcholine PET/CT Undertaken to Evaluate Prostate Malignancy.
Parekh A; Hagan I; Capaldi L; Lyburn I
Clin Nucl Med; 2017 Sep; 42(9):721-722. PubMed ID: 28682845
[TBL] [Abstract][Full Text] [Related]
2. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
4. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Vadrucci M; Gilardi L; Grana CM
Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
[TBL] [Abstract][Full Text] [Related]
6. Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT.
Meka VM; Wankhar B; Ojili V; Batchala PP
Clin Nucl Med; 2021 Aug; 46(8):e438-e439. PubMed ID: 33782311
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?
Reesink DJ; Fransen van de Putte EE; Vegt E; De Jong J; van Werkhoven E; Mertens LS; Bex A; van der Poel HG; van Rhijn BW; Horenblas S; Meijer RP
J Urol; 2016 Apr; 195(4 Pt 1):907-12. PubMed ID: 26598424
[TBL] [Abstract][Full Text] [Related]
8. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N
Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435
[TBL] [Abstract][Full Text] [Related]
9. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
Goineau A; Colombié M; Rousseau C; Sadot-Lebouvier S; Supiot S
Clin Nucl Med; 2015 Aug; 40(8):670-1. PubMed ID: 26018683
[TBL] [Abstract][Full Text] [Related]
10. Incidental Detection of Oxyphilic Papillary Thyroid Carcinoma by 18F-Fluorocholine PET/CT.
Lalire P; Zalzali M; Garbar C; Bruna-Muraille C; Morland D
Clin Nucl Med; 2016 Jun; 41(6):512-3. PubMed ID: 26914574
[TBL] [Abstract][Full Text] [Related]
11. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
12. 18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
Florimonte L; Orunesu E; Castellani M; Longari V; Cortelezzi A
Clin Nucl Med; 2016 May; 41(5):394-6. PubMed ID: 26825195
[TBL] [Abstract][Full Text] [Related]
13. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
14. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
[TBL] [Abstract][Full Text] [Related]
15. Incidental double neurinoma detected by 18F-choline PET/CT scan in a prostate cancer patient.
Dondi F; Albano D; Prandini F; Bertagna F; Giubbini R
Nucl Med Rev Cent East Eur; 2020; 23(1):40-41. PubMed ID: 32779174
[No Abstract] [Full Text] [Related]
16. Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding.
Cuppari L; Evangelista L
Clin Nucl Med; 2018 Aug; 43(8):593-594. PubMed ID: 29847318
[TBL] [Abstract][Full Text] [Related]
17. Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT.
Vija Racaru L; Gabiache E; Fontaine S; DʼAure D; Mourey L; Courbon F; Zerdoud S
Clin Nucl Med; 2019 Feb; 44(2):e101-e103. PubMed ID: 30516690
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
19. PET in prostate and bladder tumors.
Lee ST; Lawrentschuk N; Scott AM
Semin Nucl Med; 2012 Jul; 42(4):231-46. PubMed ID: 22681672
[TBL] [Abstract][Full Text] [Related]
20. Pituitary Non-Functioning Adenoma Disclosed at 18F-Choline PET/CT to Investigate a Prostate Cancer Relapse.
Maffione AM; Mandoliti G; Pasini F; Colletti PM; Rubello D
Clin Nucl Med; 2016 Oct; 41(10):e460-1. PubMed ID: 27500509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
